Semaglutide is a synthetic GLP-1 receptor agonist investigated for its interactions with glucagon-like peptide-1 receptor (GLP-1R) signaling pathways and downstream pancreatic beta cell and hypothalamic regulatory mechanisms. It has been studied for its observed effects on insulin secretion dynamics, glucagon suppression pathways, and hypothalamic energy substrate regulation in experimental models.
